Stopping azithromycin mass drug administration for trachoma: A systematic review.

• Main Authors: Hamidah Mahmud (Author), Emma Landskroner (Author), Abdou Amza (Author), Solomon Aragie (Author), William W Godwin (Author), Anna de Hostos Barth (Author), Kieran S O'Brien (Author), Thomas M Lietman (Author), Catherine E Oldenburg (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years. Azithromycin targets the ocular strains of Chlamydia trachomatis that cause trachoma. Regio...